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Rabbit antiserum was generated against the N-terminus of human
GPR30 followed by peptide afﬁnity puriﬁcation. In this article, the
methodology used and validation data are presented. The peptide
afﬁnity puriﬁed polyclonal antibody speciﬁcally detects human
GPR30 in ELISA and on western blots of total protein prepared
from human breast cancer cell lines.
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Value of the data
 The antibody generated can serve as a tool for basic and clinical research in the ﬁeld of GPR30
biology.1. Data
After immunization of two rabbits (A and B) with the peptide antigen, the antiserum harvested
from the third bleed of rabbit B that was collected after the seventh booster, was found to be the most
reactive compared to pre-immune serum (Fig. 1). Western blots of total protein prepared from human
cell lines with this antiserum resulted in the detection of 52 kDa band of GPR30 along with other
non-speciﬁc proteins, which were also detected by pre-immune serum or secondary antibody alone
(Figs. 2 and 3). The afﬁnity puriﬁed antibody obtained from the antiserum (third bleed) of rabbit B
showed similar reactivity to that of the antiserum (Fig. 4). It produced clean western blotting results,
in which, only one 52 kDa band of GPR30 was detected (Fig. 5).2. Experimental design, materials and methods
2.1. Experimental design
Rabbits were immunized with N-terminus peptide of human GPR30 and hyperimmune serumwas
collected after several boosters. Immunoreactivity of the immune serum was checked by indirect
ELISA and the antiserum with the highest reactivity was tested for the speciﬁcity by western blotting.Pre 1st 3rd
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mune sera using a protocol described in Materials and reagents (Section 2.4). Immune sera of B
e as compared to those obtained from A. Third bleed of B was most reactive.
Fig. 2. Quality assessment of antiserum against N-terminus of GPR30. Protein lysates prepared from a panel of breast cancer
cell lines were fractionated by 10% SDS-PAGE under denaturing conditions and transferred to nitrocellulose membranes.
Membranes were subjected to western blotting analysis followed by chemiluminiscence detection. The primary antibodies for
each of the above panels are- A. 1 in 1000 dilution of antiserum from Rabbit B (bleed 3); B. No primary antibody; C. 1 in 5000
dilution of commercial anti-β-actin antibody.
Fig. 3. Quality assessment of antiserum against N-terminus of GPR30. Protein lysates prepared from a panel of breast cancer
cell lines were fractionated by 10% SDS-PAGE under denaturing conditions and transferred to nitrocellulose membrane.
Membranes were subjected to western blotting analysis followed by chemiluminiscence detection. The primary antibodies for
each of the above panels are- A. 1 in 10,000 dilution of antiserum from Rabbit B (bleed 3); B. 1 in 10,000 dilution of pre-immune
serum from Rabbit B; C. 1 in 5000 dilution of commercial anti-β-actin antibody.
M.C. Manjegowda et al. / Data in Brief 7 (2016) 1015–1020 1017Upon conﬁrmation of speciﬁcity, immunoglobulins were afﬁnity puriﬁed and reconﬁrmed by indirect
ELISA and western blotting.
2.2. Materials and reagents
Plasticware for cell culture was from Tarsons (Kolkata, India) and Greiner Bio-One (GmbH, Ger-
many). Phenol red-containing media (DMEM and RPMI-1640) and fetal bovine serum (FBS) for cell
culture were from Gibco (NY, USA). Radioimmunoprecipitation assay (RIPA) buffer was purchased
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Fig. 4. Indirect ELISA for testing the reactivity of the peptide afﬁnity puriﬁed antibody. Puriﬁed antibody shows similar
reactivity as that of the original antiserum (Rabbit-B third bleed).
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Fig. 5. Detection of GPR30 in total protein by afﬁnity puriﬁed antibody. Proteins were fractionated by 10% SDS-PAGE under
denaturing conditions and transferred to nitrocellulose membranes. Membranes were subjected to western blotting analysis
followed by chemiluminiscence detection. The anti-β-actin antibody was used in a dilution of 1:5000 and the afﬁnity puriﬁed
primary antibody was used in a dilution of 1:15,000.
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(CA, USA). Nitrocellulose membrane (0.45 m) used for western blotting was from Genetix (New Delhi,
India). Anti-β-actin mouse polyclonal antibody was purchased from Ambion (Cat. #AM4302). Anti-
biotics and trypsin-EDTA were purchased from HiMedia (Mumbai, India). All other chemicals and
buffers were from SRL (Mumbai, India) or Merck (Mumbai, India).
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Polyclonal antibody generation and peptide afﬁnity puriﬁcation was performed at Abgenex Pvt.
Ltd., Bhubaneswar, India. N-terminus peptide (MDVTSQARGVGLEMYPGTAQPAA) [1] of GPR30 was
chemically synthesized with an extra cysteine residue at the C-terminus of the peptide. The peptide
was cross-linked to Keyhole Limpet Haemocyanin (KLH, Pierce, Cat. #77600) using maleimide-
sulfhydryl chemistry. KLH was activated by treating with sulfosuccinimidyl 4-(N-maleimidomethyl)
cyclohexane-1-carboxylate (Sulfo-SMCC, Pierce, Cat. #22322). Maleimide-activated KLH was then
puriﬁed by gel ﬁltration chromatography and mixed with peptide for cross-linking. Efﬁciency of
conjugation was assessed by determining the free sulfhydryl groups before and after conjugation
using Ellman's reagent (Pierce, Cat. # 22582). Two rabbits (A and B) were immunized with antigen
(KLH conjugated peptide) in Complete Freund's Adjuvant (CFA) or Incomplete Freund's Adjuvant (IFA)
after the collection of pre-immune serum. The ﬁrst immune serum was collected after primary
immunization (200 mg antigen/rabbit in CFA) and ﬁve boosters (100 mg antigen/rabbit in IFA). Sub-
sequently, the next two batches (second and third bleeds) of immune sera were collected after 6th and
7th boosters, respectively. First and third batches of immune sera were tested for immune reactivity
by indirect ELISA (Fig. 1). Pre-immune serum served as negative control. Amongst the bleeds col-
lected, the third bleed of rabbit B was found to be the most reactive (Fig. 1). The immune serum from
third bleed of rabbit B detected the 52 kDa band of GPR30 (Fig. 2A) which is consistent with other
reports [2,3]. Several non-speciﬁc bands were also observed. However, the non-speciﬁc bands were
also detected on western blots probed only with the secondary antibody (Fig. 2B). As shown in Fig. 3A,
a speciﬁc 52 kDa band of GPR30 was detected in breast cancer cell lines along with other non-
speciﬁc bands which were also detected by the pre-immune serum (Fig. 3B). This immune serum was
afﬁnity puriﬁed against the immunogenic peptide using the sulfo-link matrix. Immunoreactivity of
the afﬁnity puriﬁed antibody was conﬁrmed by indirect ELISA (Fig. 4). This antibody detected a single
prominent 52 kDa GPR30 band against a much cleaner background on western blots of total pro-
teins from breast cancer cell lines (Fig. 5).2.4. Indirect ELISA
On day 1, the peptide antigen (200ng/well) was coated on a 96-well plate (Nunc-Immuno plate,
Cat. #439454, F96 Cert. MaxiSorp) for 2 h at room temperature followed by overnight incubation at
4 °C. On day 2, the plates were kept on a shaker at room temperature for 2 h. The wells were then
washed with phosphate buffered saline containing 0.05% Tween 20 (PBST), followed by blocking with
5% skimmed milk in PBST for 1 h. After three washes with PBST, 100 μL per well of primary antibody
(diluted 1:5000 in PBST containing 1% skimmed milk) was added to each well and incubated at room
temperature. After 2 h the wells were washed as above. 100 μL of HRP-conjugated secondary antibody
(1:5000 diluted in PBST containing 1% skimmed milk) was added to each well and incubated for 1 h.
After three washes with PBST, 100 mL of 1X TMB/H2O2 solution was added and kept in dark for 3–
5 min. Thereafter, the 96-well plate was read at 450 nm.2.5. Cell culture
MCF-7 cell line was a kind gift from Dr. Dipak Datta (CDRI, Lucknow, India). T47D and BT474 were
gifted by Dr. Prathibha Ranganathan (CHG, Bangalore, India). MDA-MB-231 cells were procured from
NCCS, Pune, India. MG11 and MZ2 are derivatives of MDA-MB-231 generated in-house. Cell lines were
cultured in a humidiﬁed CO2 incubator maintained at 37 °C and 5% CO2. MCF-7 and BT474 were
cultured in DMEM, and T47D, MDAMB-231, MG11 and MZ2 cells were cultured in RPMI-1640 med-
ium. Both the media contained phenol red and were supplemented with 10% FBS, 100 U/mL penicillin,
and 100 mg/mL streptomycin.
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Cells lysates were prepared in ice-cold RIPA buffer with protease inhibitors. Lysates were collected
in pre-chilled 1.5 mL tubes and incubated on ice for 15 min. Cell debris was removed by centrifugation
at 15,000 g for 15 min at 4 °C. Supernatants were stored as aliquots of 100 mL in 0.5 mL tubes at
20 °C until use. Total protein was estimated by Lowry's method [4]. 30 mg of total protein was
resolved by 10% SDS-PAGE and transferred to 0.45 m nitrocellulose membrane using semi-dry transfer
method. Blotting was done either at constant current (140 mA) or voltage (16 V) for 80 min. After the
transfer, blots were stained with Ponceau S and scanned. Ponceau S stain was removed by washing in
PBS for 5 min followed by a 5 min wash with Tris buffered saline containing 0.05% Tween 20 (TBST).
The blots were then blocked in 1% gelatin in TBST for 2 h at room temperature followed by overnight
incubation at 4 °C in 0.1% gelatin in TBST. Next day, the blots were brought to room temperature and
rinsed with TBST. Blots were then probed with primary antibody diluted in 0.1% gelatin in TBST for 2 h
at room temperature. Blots were washed for 30 min with TBST (310 min) to remove unbound
antibody. Blots were then incubated with HRP-tagged secondary antibody (1:5000 dilution in 0.1%
gelatin in TBST) for 1 h followed by three TBST washes of 10 min each. Bands were visualized with
enhanced chemiluminescence reagent (Santa Cruz Biotechnology, CA, USA). Chemidoc XRSþ system
(BioRad) was used to capture the images.Acknowledgements
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